ACTR10 activators encompass a diverse set of compounds that contribute to the enhancement of its function in cytoskeletal dynamics. For instance, certain activators work by increasing the levels of second messengers within the cell, which can lead to a cascade of intracellular events culminating in the promotion of actin filament formation-a process in which ACTR10 is fundamentally involved. This can be achieved via the direct stimulation of enzymes responsible for the production of these messengers, thereby upregulating the pathways that are crucial to the polymerization activity of ACTR10. Other activators exert their effect by stabilizing existing actin filaments, a mechanism that indirectly necessitates the increased activity of ACTR10 to maintain cytoskeletal integrity. By preventing the disassembly of these filaments, the cell may compensate by enhancing actin nucleation and elongation activities, in which ACTR10 plays a pivotal role.
Additionally, modulation of ACTR10's activity can be achieved through the alteration of phosphorylation states of proteins within the cell, which can have a downstream impact on ACTR10's incorporation into actin filaments. Inhibitors of protein phosphatases create a cellular environment rich in phosphorylated substrates that can interact with ACTR10, potentially augmenting its function. Conversely, other compounds work by influencing the microtubule network, either by stabilizing or disrupting it, leading to a knock-on effect on the actin cytoskeleton and hence on ACTR10's activity. These shifts in cytoskeletal dynamics compel the cell to adjust its internal scaffold, with ACTR10 being a critical mediator in this rearrangement. For example, the stabilization of microtubules may necessitate a reorganization of actin filaments, prompting ACTR10 to participate more actively in actin-related processes to accommodate the changes. In contrast, the disruption of microtubules can lead to a compensatory increase in actin filament assembly to preserve cellular structure and function, again implicating ACTR10 as a key player.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate downstream targets that interact with ACTR10, possibly enhancing its incorporation into actin filaments. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments and can increase the nucleation and elongation activity of ACTR10 by preventing filament disassembly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β leading to stabilization of microtubules, which may interact with actin filaments and ACTR10, potentially enhancing its function in cytoskeletal dynamics. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins that could interact with ACTR10, thereby enhancing its activity in actin filament turnover. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, it inhibits protein phosphatases, leading to a state that could enhance the interaction of phosphorylated proteins with ACTR10, promoting its activity in the cytoskeleton. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase (MLCK), altering cytoskeletal dynamics that could facilitate the activity of ACTR10 in actin filament organization. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Binds to the barbed ends of actin filaments, blocking polymerization and depolymerization, which can create a cellular environment that compensates by increasing the activity of actin-related proteins like ACTR10. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule networks, potentially increasing the need for actin filament stabilization and enhancing the role of ACTR10 in actin dynamics. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
Donates nitric oxide which can lead to S-nitrosylation of cytoskeletal proteins, potentially modifying the interaction with ACTR10 and enhancing its activity in actin assembly. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and can indirectly enhance the actin filament formation by ACTR10, as cells may compensate for rigid microtubules by altering actin dynamics. | ||||||